Raymond James raises Lexeo Therapeutics target price to $42 from $24
LXEO•Raymond James raised its target price for Lexeo Therapeutics to $42 from $24.
Related News

Australian dollar hits 10-month low; kiwi hovers near 2009 crisis-era levels
TLT•

Agnico Eagle Mines target price cut to $227 from $241
AEM•

US Treasury yields top 5% as inflation persists, Europe Capital Partners says
TLT•

Reaction to US AI chip curbs that threaten data centre boom
SMH•

Kimberly-Clark: JPMorgan resumes coverage with neutral rating; target price $113
KMB•